VKTX in the 13F filings
Viking Therapeutics Inc · CUSIP 92686J106
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 27
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 17,699,494
- combined, among listed positions
- Reported value
- $690m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 20 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,022,335.
Managers listing VKTX in Q2 2026
27 of 27 holders
Largest increases and reductions, by shares
Increases
- Point72 Asset Management LPnew position · 473,308 shares now+473,308
- Fidelity (FMR LLC)existing position · 6,335,756 shares now+311,003
- ExodusPoint Capital Management LPexisting position · 361,126 shares now+291,499
- Millennium Management LLCexisting position · 498,172 shares now+247,647
- AQR Capital Management LLCexisting position · 200,958 shares now+188,786
Reductions
- Two Sigma Investments LPexisting position · 3,937,414 shares now-494,728
- Citadel Advisors LLCexisting position · 951,515 shares now-310,706
- D. E. Shaw & Co.existing position · 1,605,994 shares now-70,719
- Marshall Wace LLPexisting position · 42,767 shares now-47,593
- Brevan Howard Capital Management LPexisting position · 29,259 shares now-676
New positions and exits
New (6)
Exited (1)
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2018 | 1 | $949k | n.a. | n.a. |
| Q3 2018 | 3 | $20m | n.a. | n.a. |
| Q4 2018 | 1 | $161k | n.a. | n.a. |
| Q1 2019 | 1 | $6.5m | n.a. | n.a. |
| Q2 2019 | 2 | $5.4m | n.a. | n.a. |
| Q3 2019 | 1 | $751k | n.a. | n.a. |
| Q4 2020 | 1 | $112k | n.a. | n.a. |
| Q1 2021 | 1 | $245k | n.a. | n.a. |
| Q2 2021 | 2 | $1.0m | n.a. | n.a. |
| Q3 2021 | 2 | $769k | n.a. | n.a. |
| Q4 2021 | 1 | $627k | n.a. | n.a. |
| Q1 2022 | 1 | $290k | n.a. | n.a. |
| Q2 2022 | 1 | $849k | n.a. | n.a. |
| Q3 2022 | 2 | $3.5m | n.a. | n.a. |
| Q4 2022 | 3 | $13m | n.a. | n.a. |
| Q1 2023 | 4 | $71m | n.a. | n.a. |
| Q2 2023 | 1 | $57m | n.a. | n.a. |
| Q3 2023 | 3 | $54m | n.a. | n.a. |
| Q4 2023 | 2 | $138m | 2 | 1 |
| Q1 2024 | 7 | $1.6bn | 5 | 2 |
| Q2 2024 | 5 | $961m | 5 | 1 |
| Q3 2024 | 5 | $1.1bn | 2 | 3 |
| Q4 2024 | 6 | $794m | 4 | 3 |
| Q1 2025 | 4 | $61m | 4 | 2 |
| Q2 2025 | 3 | $72m | 3 | 0 |
| Q3 2025 | 6 | $117m | 6 | 0 |
| Q4 2025 | 6 | $202m | 18 | 9 |
| Q1 2026 | 2 | $156m | 10 | 18 |
| Q2 2026 | 4 | $183m | 20 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
VKTX and LLY →VKTX and JNJ →VKTX and VRTX →Choose a stock to compare with VKTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own VKTX, latest filings →Back to the 13F Explorer →